Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2005
09/01/2005US20050192259 A sustained release formulation of an aldosterone antagonist orally administered about 6-12 hours prior to the acrophase to provide a profile of plasma drug concentration corresponding to the diurnal cycle of plasma aldosterone concentration; hypotensive agents; circadi rhythm; cardiovascular disorders
09/01/2005US20050192238 Modulation of the expression of genes dependent on stat-1
09/01/2005US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation
09/01/2005US20050191747 Recombinant bovine immunodeficiency virus based gene transfer system
09/01/2005US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
09/01/2005US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders
09/01/2005US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders
09/01/2005US20050191641 Nucleotide sequences coding hydrolase for use as tool in identifying modulators for prevention and treatment of digestion, coagulation, diabetic, cell proliferative, urogenital, eating and nervous system gynecological disorders
09/01/2005US20050191612 Using g protein coupled receptors as tool in identifying modulators for treatment and prevention of diabetes; antidiabetic agents
09/01/2005US20050191374 Soluble composition containing sporopollenin and the use thereof
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells
09/01/2005DE10247680B4 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase New bicyclic inhibitors of hormone sensitive lipase
09/01/2005DE102004008112A1 New 8-aminopiperidinyl-xanthine derivatives, useful for treating e.g. diabetes, arthritis and osteoporosis, are inhibitors of dipeptidylpeptidase-IV
09/01/2005DE102004004906A1 New oxygen-bridged angucyclinone derivatives, useful for treating bacterial infections and dementia, are modulators of intracellular calcium levels
09/01/2005CA2560446A1 Alkyl carbamate-substituted butyrolactones serving as lipase inhibitors
09/01/2005CA2559398A1 Pyrrole-3-carboxamide derivatives for the treatment of obesity
09/01/2005CA2557837A1 Fructoseamine 3 kinase and the formation of collagen and elastin
09/01/2005CA2555826A1 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
09/01/2005CA2555133A1 Substituted quinoline compounds
09/01/2005CA2554686A1 Compounds
09/01/2005CA2554310A1 Benzamide derivatives and their use as glucokinase activating agents
09/01/2005CA2552094A1 Amidine derivatives for treating amyloidosis
09/01/2005CA2548218A1 Imidazole-based hmg-coa reductase inhibitors
09/01/2005CA2498966A1 Novel pyrazole analogs acting on cannabinoid receptors
09/01/2005CA2498682A1 System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
08/2005
08/31/2005EP1568772A2 Human growth hormone variants
08/31/2005EP1568771A2 Human growth hormone variants
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
08/31/2005EP1568380A1 Preventive or remedy for diseases caused by hyperglycemia
08/31/2005EP1568377A1 Cysteine protease inhibitor
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1568285A1 Agent for inhibiting rise in blood glucose level, agent for inhibiting body fat accumulation and edible material
08/31/2005EP1567517A1 Anilinopyrazole derivatives useful for the treatment of diabetes
08/31/2005EP1567493A1 Phenyl substituted piperidine compounds for use as ppar activators
08/31/2005EP1567487A2 Open chain prolyl urea-related modulators of androgen receptor function
08/31/2005EP1567187A1 Proteins involved in the regulation of energy homeostasis
08/31/2005EP1567136A1 Pde4 and pde3/4 inhibitors for use in the treatment of cachexia
08/31/2005EP1478437B1 Acc inhibitors
08/31/2005EP1430057B1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives
08/31/2005EP1392714B1 Steroids as agonists for fxr
08/31/2005EP1392288B1 Medicament containing an effector of the glutathione metabolism (ampbroxol) together with alpha-lipoic acid for treating diabetes mellitus
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005EP1363516B1 An improved process for preparing simvastatin
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005EP1240168B1 Bicyclic inhibitors of glycogen synthase kinase 3
08/31/2005EP1237875B1 Substituted imidazole neuropeptide y y5 receptor antagonists
08/31/2005EP1221444B1 Fused imidazole compounds and remedies for diabetes mellitus
08/31/2005EP1150579B1 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven carbon fatty acid
08/31/2005EP1070048B1 Calcilytic compounds
08/31/2005EP0984780B1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
08/31/2005EP0888333B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
08/31/2005EP0882718B1 Benzimidazole derivatives
08/31/2005CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
08/31/2005CN1662655A Beta glucan-containing fat and oil compositions and novel microorganism capable of producing beta-glucan
08/31/2005CN1662644A Method of producing human beta cell lines
08/31/2005CN1662549A Glucocorticoid receptor ligands for the treatment of metabolic disorders
08/31/2005CN1662544A Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662539A [1, 4]diazocino [7, 8, 1-hi]indole derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662534A 1, 2, 3, 4, 7, 8-hexahydro-6h-[1, 4]diazepino[6, 7, 1-1j]quinoline derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662533A [1, 4]diazepino[6, 7, 1-ij]quinoline derivatives as anti psychotic and antiobesity agents
08/31/2005CN1662531A Hetero-bicyclic compounds
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/31/2005CN1662524A Indole derivatives useful as histamine h3 antagonists
08/31/2005CN1662523A Novel process
08/31/2005CN1662522A Novel compounds, their use and preparation
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662511A Pharmaceutical salts of reboxetine
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662498A Novel tetrahydropyridine derivatives as renin inhibitors
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662495A Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662494A Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662493A Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662487A Amide linker peroxisome proliferator activated receptor modulators
08/31/2005CN1662258A Compositions comprising dietary fat complexer and methods for their use
08/31/2005CN1662257A Combination of PDE5 inhibitors with angiotensin II receptor antagonists
08/31/2005CN1662252A Acidic insulin preparations with improved stability
08/31/2005CN1662246A Combination therapy wherein a serotonin reuptake inhibitor is used
08/31/2005CN1662245A (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
08/31/2005CN1662243A Pharmaceutical composition
08/31/2005CN1662237A Controlled-release drug composition
08/31/2005CN1662230A Benzoic acid derivatives as modulators of PPAR alpha and gamma
08/31/2005CN1662226A Monocompartment osmotic controlled drug delivery system
08/31/2005CN1662222A Free-flowing, powdery composition containing alpha-liponic acid (-derivatives)
08/31/2005CN1662152A Nutritious compositions for detoxification and cancer prevention
08/31/2005CN1662142A Oil body associated protein compositions, methods of and use thereof for reducing the risk of cardiovascular disease
08/31/2005CN1661110A Novel targets for obesity from fat tissue
08/31/2005CN1661109A Novel targets for obesity from skeletal muscle
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660842A Preparation of 4-hydroxy-3-nitro-2(1h)-pyridone from 2-hydroxy-3-cyano-4-methoxypyridine
08/31/2005CN1660840A Phthalazine derivatives for treating inflammatory diseases
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660834A Compound containing o-naphthaquinone and application
08/31/2005CN1660833A Compound containing structure of o-naphthaquinone and application
08/31/2005CN1660754A Ramification biphenyl dienones and application
08/31/2005CN1660732A Technique for extracting and preparing policosanol and application
1 ... 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 ... 1298